Nile Pharmaceuticals and Chemical Industries Company

E£288.01As of Sun 8 Nov 2026, 12:00 UTC
EGX:NIPHHealthcare
Country Egypt
PE (Fwd) •••
TSR 10Y CAGR 67.72%
Div yield 0.69%
ROE 28.26%
Pharmaceutical Preparations
Beta (5Y) 0.71
PE TTM 56.17
TSR TTM 152.64%
Mkt cap E£14.40B
ROIC 17.42%
SE Grade™
Value
Quality
Moat
Consensus
Reference
E£352
22.24%
51.02%
Buy 10|11|4|4|2
2Q26
3Q26
4Q26
1Q27
Earnings per shareE£
3.69
3.92
4.10
4.37
23.11%
35.80%
27.94%
32.17%
RevenueE£M
635.6
629.3
647.9
676.0
5.35%
3.90%
2.32%
5.16%
Peers (US$260.8M)
Cap (US$)
PE
263.2M
10.45x
Capital
TTM
5Y
10Y
Leveragex
1.084
0.233
0.287
EBIT/Intx
6.747
0.171
0.175
Own earn%
(51.96)
(81.44)
(66.89)
Sh yield%
21.96
18.54
18.42
Owners
Insiders/Inst%
8.38
84.44
Short interest%
2.23
SBC / revenue%
2.95
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
0–5
$1 testx
0.0
Incr. ROIC%
2